Osmind is a healthcare technology startup providing software and clinical insights for mental health.
Osmind is on a mission to maximize access to innovative mental health treatments.
Osmind was founded in 2020 by Lucia Huang and Jimmy Qian. The company is headquartered in Mountain View, California.
Osmind’s electronic health record is uniquely designed for mental health providers, especially those who treat refractory mental health conditions. About a third of people with depression are considered treatment-resistant, meaning they have failed two or more adequate trials of conventional therapies (including medications and psychotherapy).
Osmind currently serves over 20,000 mental health patients in over 125 practices in over 30 states, including some of the largest treatment-resistant mental health clinics in the country.
Osmind is backed by General CatalystGeneral Catalyst, Y Combinator, What If Ventures, Pear VC, 20|20 Fund, Jeffrey Leiden MD, PhD (Executive Chairman of Vertex Pharmaceuticals) and others. The company raised $2M in Seed round on Oct 14, 2020. This brings Osmind's total funding to $2.2M to date.